Jill Ettinger, Author at PsyNews.com

Home Authors Posts by Watertime

342 POSTS 0 COMMENTS

The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters

How Red Light Holland Is Bringing Psilocybin Truffles Mainstream

PsyCap Recap: 3 Key Takeaways From the Psygen Industries Presentation at...

Understanding the Strengths & Weaknesses of Different Patent Types

The Reddit Revolution Riles up Retail Investors: How Short Selling Gamestop...

The Critical Role of Patents in Novel Drug Development

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...

Psychedelics Versus Cannabis: Exploring their Impact on Treating Mental Illness

SALT Talks: Psychedelics with Sa’ad Shah (Noetic Fund) & JR Rahn...

Progressive Law Firm Zuber Lawler Is at Forefront of Modern Psychedelic...

1...303132...35 Page 31 of 35

Michael Ryoshin Sapiro, PsyD – Truth Medicine, Psychedelics, and Living Your...

What the Cancer Community Actually Needs from Psychedelic Care

Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime